Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 August 2025 | Story Somila Nazo | Photo Supplied
Prof Martin Nyaga
Prof Martin Nyaga delivered a keynote on Africa’s scientific leadership in genomics and global health at the African Academy of Sciences Summit in Accra, Ghana.

Prof Martin Nyaga, one of Africa’s foremost experts in genomics and global health, recently delivered a powerful call for Africa’s leadership in global science at the African Academy of Sciences (AAS) Summit in Accra, Ghana. 

As Head of the Next Generation Sequencing (NGS) Unit at the University of the Free State (UFS) and Director of the WHO Collaborating Centre for Vaccine Preventable Diseases Surveillance and Pathogen Genomics, Prof Nyaga urged the scientific community to recognise Africa not just as a participant in global research, but as a driver of innovation and change. 

 

A summit of vision and collaboration 

Themed Unpacking the Pact for the Future: Imperatives for Advancing Scientific Cooperation with Africa, the summit took place from 2 – 4 July 2025. Hosted by the AAS in partnership with the African Union, the Government of Ghana, the University of Ghana, and other global partners, the summit brought together leading scientists, policymakers, and international stakeholders to discuss Africa’s role in shaping the future of global science, research and innovation. 

The event was attended by high-level dignitaries, including the President of Ghana, His Excellency John Dramani Mahama, and the former President of Nigeria, His Excellency Olusegun Obasanjo – a clear indication of strong political will to prioritise science, health and innovation across the continent. 

 

Advancing Africa’s voice in global health 

On 2 July 2025, Prof Nyaga delivered his keynote address, Advances, Opportunities and Priorities for Global Health in Africa. He highlighted Africa’s growing capabilities in genomics and public health, underscoring the opportunities for scientific leadership. 

Following his address, he joined an expert panel with representatives from Tanzania, Ghana and Nigeria to discuss strategies for advancing scientific cooperation in global health. His contributions focused on: strengthening research collaborations; building capacity within Africa; increasing African ownership in health innovations, and enhancing the translation of research into policy and practice. 

Prof Nyaga also used the platform to spotlight the work of the UFS Next Generation Sequencing (UFS-NGS) Unit. As a WHO Collaborating Centre, the unit plays a critical role in pathogen tracking, monitoring vaccine-preventable diseases, and supporting public health preparedness across Africa and beyond. 

 “This engagement provided an opportunity to highlight the impactful research from the UFS-NGS Unit – not only in academic publications, but in demonstrating tangible public health benefits to policy makers,” said Prof Nyaga.  “It elevated the University of the Free State’s standing as a leader in genomic science, while opening new opportunities for collaboration for South Africa and the continent. Our research priorities are increasingly shaping global health and innovation agendas.” 

 

From Ghana to the G20 

The outcomes of the summit will feed into a communiqué to be presented at the 2025 G20 Summit, to be hosted by South Africa. Prof Nyaga’s thought leadership ensures that Africa’s scientific voice - and South Africa’s research priorities - will be represented at one of the world’s most influential multilateral platforms. 

For more information about UFS partnerships in Africa, contact the Office for International Affairs at partnerships@ufs.ac.za.  

News Archive

Blood tests for players at FIFA Confederations Cup
2009-03-21

Football stars coming to South Africa to play in the FIFA Confederations Cup tournament in June will not only have their urine tested for illegal substances but their blood as well.

This will be the first time that blood samples from sportsmen or women will be tested in South Africa.

“Blood testing is a new regulation from the World Anti-Doping Agency (WADA) and will be implemented in our laboratory for the FIFA Confederations Cup in June,” according to Dr Pieter van der Merwe, Head of the SA Doping Control Laboratory at the University of the Free State (UFS), the only testing facility of its kind in Southern Africa.

Although urine will still be tested, blood tests have become compulsory, because the substances used by sports men and women are becoming more sophisticated.

“Some substances, such as the growth hormone, can more easily be detected in blood. It is more difficult to determine these kinds of substances in urine,” explained Dr Van der Merwe.

“We were contracted by the International Rugby Board (IRB) to conduct the testing for the 7’s World Cup Rugby Tournament that was recently held in Dubai and by FIFA to do the testing for the Confederations Cup this year as well as the 2010 World Cup. This demonstrates the confidence of International Sport Federations in the quality and standard of work produced by this facility at the UFS,” he said.

The results of all tests done for the national programme in South Africa are sent to the Institute for Drug Free Sport based in Cape Town from where it is reported to the various sports federations. However, the rugby and soccer results are reported directly to the IRB and FIFA respectively.

The move to incorporate blood tests in the testing process has resulted in the expansion of the facility’s infrastructure.

“A new extension will be built for us in the near future in order for us to accommodate the conducting of urine and blood testing,” says Dr van der Merwe.

Media Release
Issued by: Anton Fisher
Director: Strategic Communication
Tel: 051 401 2749
Cell: 072 207 8334
E-mail: fishera.stg@ufs.ac.za  
20 March 2009

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept